Company Filing History:
Years Active: 2017
Title: Ryan Pratt - Innovator in Pulmonary Surfactant Treatment
Introduction
Ryan Pratt is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pulmonary medicine through his innovative approaches to treating respiratory conditions. His work focuses on enhancing pulmonary surfactants, which play a crucial role in lung function.
Latest Patents
Ryan Pratt holds a patent for a method of treating pulmonary surfactant dysfunction or respiratory distress syndrome by administering cyclodextrin or a derivative thereof. This invention relates to a method for enhancing a surfactant, particularly a pulmonary surfactant. It also includes a method for producing a surfactant enhancement agent and a use of this agent for improving surfactant function. Furthermore, the invention addresses oxidative damage to pulmonary surfactant by incorporating a cholesterol-sequestrating agent, such as cyclodextrin. The patent demonstrates that MβCD, a cholesterol-sequestrating agent, can restore dysfunctional surfactant removed from the lungs of children with cystic fibrosis and non-CF bronchiolitis to normal function.
Career Highlights
Ryan Pratt is currently associated with Solaero Med Inc., where he continues to develop innovative solutions for respiratory health. His work has the potential to significantly impact the treatment of patients suffering from surfactant dysfunction.
Collaborations
Ryan collaborates with esteemed colleagues, including Matthias W Amrein and Lasantha C Gunasekara, to advance research and development in pulmonary treatments.
Conclusion
Ryan Pratt's contributions to the field of pulmonary medicine through his innovative patent highlight his commitment to improving respiratory health. His work exemplifies the importance of innovation in addressing complex medical challenges.